Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03338192 · ClinicalTrials.gov registry record
Examining Racial and SocioEconomic Disparities (ERASED) in Chronic Low Back Pain Study
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 281
- Enrollment target
NCT03338192: Completed study, sponsored by University of Alabama at Birmingham.
NCT03338192 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 281 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03338192 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 281 participants
- Enrollment target
Study Summary
It remains unclear whether certain disadvantaged subgroups of society may be at heightened risk for poor chronic low back pain (cLBP) outcomes. The overall aim of this study is to incorporate a socioeconomic framework to characterize racial differences in cLBP severity and disability. Further, guided by the theory of fundamental causes, we aim to examine racial and socioeconomic status differences in biopsychosocial predictors of cLBP outcomes, particularly endogenous pain modulation.
Primary Outcome
The Brief Pain Inventory Short-Form (BPI-SF) was used to assess clinical pain severity. Four items assessed participants' average, least, and worst pain over the past 24hours, as well as current pain (0=no pain, 10=pain as bad as you can imagine). These 4 items were averaged for a total score (range: 0-10).
Interventions
- OTHER QST
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 281 participants |
| Start Date | 2017-10-15 |
| Est. Completion | 2024-01-31 |
What the finished NCT03338192 record still lists
NCT03338192 is an observational study that tracks outcomes without assigning an intervention. The registered 281 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which QST is the first listed.
NCT03338192 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03338192 about?
NCT03338192 is a clinical study titled "Examining Racial and SocioEconomic Disparities (ERASED) in Chronic Low Back Pain Study". It remains unclear whether certain disadvantaged subgroups of society may be at heightened risk for poor chronic low back pain (cLBP) outcomes. The overall aim of this study is to incorporate a socioeconomic framework to characterize racial differences in cLBP severity and disability. Further, guide...
What is the current status of trial NCT03338192?
This trial is currently completed. The enrollment target is 281 participants. The study started on 2017-10-15. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT03338192?
The interventions under investigation include: QST (OTHER).
Who is sponsoring clinical trial NCT03338192?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04521231 · 281 participants · Phase 1
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
- NCT06190730 · 281 participants · NA
REmote Symptom COllection to improVE postopeRative Care
- NCT02860364 · 282 participants · NA
Comparing Hypothermic Temperatures During Hemiarch Surgery
- NCT04867395 · 282 participants · NA
A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI